Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1952 1
1957 1
1962 2
1964 4
1965 1
1966 4
1967 1
1968 3
1969 5
1971 6
1972 2
1973 2
1974 4
1975 4
1976 8
1977 10
1978 5
1979 6
1980 1
1981 6
1982 2
1983 5
1984 9
1985 5
1986 9
1987 6
1988 6
1989 5
1990 9
1991 4
1992 9
1993 10
1994 9
1995 13
1996 5
1997 8
1998 12
1999 10
2000 16
2001 14
2002 15
2003 18
2004 20
2005 15
2006 8
2007 8
2008 16
2009 18
2010 11
2011 21
2012 22
2013 30
2014 20
2015 34
2016 28
2017 30
2018 32
2019 34
2020 44
2021 40
2022 55
2023 47
2024 61
2025 35

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

860 results

Results by year

Filters applied: Free full text. Clear all
Page 1
Lactic acid in the vaginal milieu modulates the Candida-host interaction.
Rosati D, Valentine M, Bruno M, Pradhan A, Dietschmann A, Jaeger M, Leaves I, van de Veerdonk FL, Joosten LAB, Roy S, Stappers MHT, Gow NAR, Hube B, Brown AJP, Gresnigt MS, Netea MG. Rosati D, et al. Virulence. 2025 Dec;16(1):2451165. doi: 10.1080/21505594.2025.2451165. Epub 2025 Jan 22. Virulence. 2025. PMID: 39843417 Free PMC article.
Chemical composition of the traditional Chinese medicine compound (ICAM), its antifungal effects against Candida albicans, and the underlying Mechanisms: Therapeutic potential and safety evaluation for vulvovaginal candidiasis.
Zhu S, Sun J, Bi X, Wang Z, Yang F, Ta R, Su C, Wu X, Han K, Lan M, Hu H, Li H, Li Y. Zhu S, et al. J Ethnopharmacol. 2025 May 28;348:119844. doi: 10.1016/j.jep.2025.119844. Epub 2025 Apr 18. J Ethnopharmacol. 2025. PMID: 40254107 Free article.
Efficacy and safety of vaginal suppositories containing combination of Natamycin and Lactulose in treatment of vulvovaginal candidiasis: international, randomized, controlled, superiority clinical trial (combination of Natamycin and Lactulose for treatment of vulvovaginal candidiasis).
Volkova ON, Amel'chenko EV, Makeeva OV, Tolmachev SA, Lesovaya EA, Zacharia LC, Dikovskiy AV. Volkova ON, et al. BMC Womens Health. 2025 Feb 20;25(1):77. doi: 10.1186/s12905-025-03616-3. BMC Womens Health. 2025. PMID: 39979898 Free PMC article. Clinical Trial.
Genital-oral transmission of Candida lusitaniae.
Veraldi S, Bortoluzzi P, Germiniasi F, Grancini A. Veraldi S, et al. Int J STD AIDS. 2025 Feb;36(2):158-160. doi: 10.1177/09564624241296582. Epub 2024 Oct 29. Int J STD AIDS. 2025. PMID: 39471997 Free PMC article.
Novel Isoxazole-Based Antifungal Drug Candidates.
Bąchor U, Brożyna M, Junka A, Chmielarz MR, Gorczyca D, Mączyński M. Bąchor U, et al. Int J Mol Sci. 2024 Dec 19;25(24):13618. doi: 10.3390/ijms252413618. Int J Mol Sci. 2024. PMID: 39769380 Free PMC article.
Efficacy and safety of oral ibrexafungerp in Chinese patients with vulvovaginal candidiasis: a phase III, randomized, double-blind study.
Wang X, Wang W, Li J, An R, Chen L, Lin J, Xu D, Qiu J, Song W, Patiman M, Ruan H, Wang G, Xue F, Wang X, Luo X, Ruan Q, Shi L, Zhang C, Hu L, Wang S, Shi H, Wang X, Zhang S, Li Y, Lu J, Wang B, Xu H, Ye H, Zhang B, Zhang C, Qian S, Wu Q, Jia W, Li C, Liao Q. Wang X, et al. Infection. 2024 Oct;52(5):1787-1797. doi: 10.1007/s15010-024-02233-w. Epub 2024 Apr 3. Infection. 2024. PMID: 38568411 Free PMC article. Clinical Trial.
The incidence and prevalence of serious fungal diseases in Tunisia.
Fathallah A, Chouaieb H, Saief MB, Ismaïl S, Said MB, Denning DW; in association with the Tunisian Society for Infectious Diseases (Société Tunisienne de Pathologie Infectieuse (STPI)). Fathallah A, et al. J Mycol Med. 2024 Jun;34(2):101479. doi: 10.1016/j.mycmed.2024.101479. Epub 2024 Apr 5. J Mycol Med. 2024. PMID: 38604083 Free article. Review.
Nanobody-mediated neutralization of candidalysin prevents epithelial damage and inflammatory responses that drive vulvovaginal candidiasis pathogenesis.
Valentine M, Rudolph P, Dietschmann A, Tsavou A, Mogavero S, Lee S, Priest EL, Zhurgenbayeva G, Jablonowski N, Timme S, Eggeling C, Allert S, Dolk E, Naglik JR, Figge MT, Gresnigt MS, Hube B. Valentine M, et al. mBio. 2024 Mar 13;15(3):e0340923. doi: 10.1128/mbio.03409-23. Epub 2024 Feb 13. mBio. 2024. PMID: 38349176 Free PMC article.
Oteseconazole versus fluconazole for the treatment of severe vulvovaginal candidiasis: a multicenter, randomized, double-blinded, phase 3 trial.
Wang X, Chen L, Ruan H, Xiong Z, Wang W, Qiu J, Song W, Zhang C, Xue F, Qin T, Zhang B, An R, Luo X, Wang W, Zhang S, Cai Y, Kang J, Deng H, Fan S, Cui M, Wang S, Luo X, Su Z, Shu J, Wang Q, Wang F, Bai J, Liao Q. Wang X, et al. Antimicrob Agents Chemother. 2024 Jan 10;68(1):e0077823. doi: 10.1128/aac.00778-23. Epub 2023 Dec 14. Antimicrob Agents Chemother. 2024. PMID: 38095426 Free PMC article. Clinical Trial.
Basic Research on Candida Species.
Abe M, Kinjo Y, Koshikawa T, Miyazaki Y. Abe M, et al. Med Mycol J. 2024;65(3):67-74. doi: 10.3314/mmj.24.006. Med Mycol J. 2024. PMID: 39218649 Free article. Review.
The pathogenic and colonization potential of Candida africana.
Kosmala D, Sertour N, Fróis Martins R, Spaggiari L, Ardizzoni A, LeibundGut-Landmann S, Pericolini E, Bougnoux ME, d'Enfert C, Legrand M. Kosmala D, et al. Microbes Infect. 2024 Jan-Feb;26(1-2):105230. doi: 10.1016/j.micinf.2023.105230. Epub 2023 Sep 20. Microbes Infect. 2024. PMID: 37734535 Free article.
Insights and advances in recurrent vulvovaginal candidiasis.
San Juan Galán J, Poliquin V, Gerstein AC. San Juan Galán J, et al. PLoS Pathog. 2023 Nov 10;19(11):e1011684. doi: 10.1371/journal.ppat.1011684. eCollection 2023 Nov. PLoS Pathog. 2023. PMID: 37948448 Free PMC article. No abstract available.
Comparing the Effect of Probiotic and Fluconazole on Treatment and Recurrence of Vulvovaginal Candidiasis: a Triple-Blinded Randomized Controlled Trial.
Mollazadeh-Narestan Z, Yavarikia P, Homayouni-Rad A, Samadi Kafil H, Mohammad-Alizadeh-Charandabi S, Gholizadeh P, Mirghafourvand M. Mollazadeh-Narestan Z, et al. Probiotics Antimicrob Proteins. 2023 Oct;15(5):1436-1446. doi: 10.1007/s12602-022-09997-3. Epub 2022 Oct 5. Probiotics Antimicrob Proteins. 2023. PMID: 36198994 Free PMC article. Clinical Trial.
A New Phenotype in Candida-Epithelial Cell Interaction Distinguishes Colonization- versus Vulvovaginal Candidiasis-Associated Strains.
Sala A, Ardizzoni A, Spaggiari L, Vaidya N, van der Schaaf J, Rizzato C, Cermelli C, Mogavero S, Krüger T, Himmel M, Kniemeyer O, Brakhage AA, King BL, Lupetti A, Comar M, de Seta F, Tavanti A, Blasi E, Wheeler RT, Pericolini E. Sala A, et al. mBio. 2023 Apr 25;14(2):e0010723. doi: 10.1128/mbio.00107-23. Epub 2023 Mar 1. mBio. 2023. PMID: 36856418 Free PMC article.
Scoping review of cytolytic vaginosis literature.
Kraut R, Carvallo FD, Golonka R, Campbell SM, Rehmani A, Babenko O, Lee MC, Vieira-Baptista P. Kraut R, et al. PLoS One. 2023 Jan 26;18(1):e0280954. doi: 10.1371/journal.pone.0280954. eCollection 2023. PLoS One. 2023. PMID: 36701339 Free PMC article.
Psychosocial impact of recurrent urogenital infections: a review.
Thomas-White K, Navarro P, Wever F, King L, Dillard LR, Krapf J. Thomas-White K, et al. Womens Health (Lond). 2023 Jan-Dec;19:17455057231216537. doi: 10.1177/17455057231216537. Womens Health (Lond). 2023. PMID: 38099456 Free PMC article. Review.
Editorial: Women and clinical microbiology 2021.
Papp-Wallace KM, Manning SD, Craney A, Kuboniwa M, Vourli S. Papp-Wallace KM, et al. Front Cell Infect Microbiol. 2022 Oct 21;12:999967. doi: 10.3389/fcimb.2022.999967. eCollection 2022. Front Cell Infect Microbiol. 2022. PMID: 36339342 Free PMC article. No abstract available.
Efficacy of Cochleated Amphotericin B in Mouse and Human Mucocutaneous Candidiasis.
Desai JV, Urban A, Swaim DZ, Colton B, Kibathi LW, Ferrè EMN, Stratton P, Merideth MA, Hunsberger S, Matkovits T, Mannino R, Holland SM, Tramont E, Lionakis MS, Freeman AF. Desai JV, et al. Antimicrob Agents Chemother. 2022 Jul 19;66(7):e0030822. doi: 10.1128/aac.00308-22. Epub 2022 Jun 14. Antimicrob Agents Chemother. 2022. PMID: 35699443 Free PMC article. Clinical Trial.
Clinical and morphopathological assay in vulvovaginal candidiasis.
Manolea MM, Istrate-Ofiţeru AM, Săndulescu MS, Camen IV, Piciu IA, Dijmărescu AL, Vrabie SC, Neamţu SD, Obleagă CV, Siminel MA. Manolea MM, et al. Rom J Morphol Embryol. 2022 Jul-Sep;63(3):511-520. doi: 10.47162/RJME.63.3.05. Rom J Morphol Embryol. 2022. PMID: 36588489 Free PMC article.
Lactobacillus acidophilus, L. plantarum, L. rhamnosus, and L. reuteri Cell-Free Supernatants Inhibit Candida parapsilosis Pathogenic Potential upon Infection of Vaginal Epithelial Cells Monolayer and in a Transwell Coculture System In Vitro.
Spaggiari L, Sala A, Ardizzoni A, De Seta F, Singh DK, Gacser A, Blasi E, Pericolini E. Spaggiari L, et al. Microbiol Spectr. 2022 Jun 29;10(3):e0269621. doi: 10.1128/spectrum.02696-21. Epub 2022 May 2. Microbiol Spectr. 2022. PMID: 35499353 Free PMC article.
Determining Susceptibility in Candida Vaginal Isolates.
Sobel JD, Akins R. Sobel JD, et al. Antimicrob Agents Chemother. 2022 Jun 21;66(6):e0236621. doi: 10.1128/aac.02366-21. Epub 2022 May 23. Antimicrob Agents Chemother. 2022. PMID: 35604210 Free PMC article.
Ibrexafungerp Versus Placebo for Vulvovaginal Candidiasis Treatment: A Phase 3, Randomized, Controlled Superiority Trial (VANISH 303).
Schwebke JR, Sobel R, Gersten JK, Sussman SA, Lederman SN, Jacobs MA, Chappell BT, Weinstein DL, Moffett AH, Azie NE, Angulo DA, Harriott IA, Borroto-Esoda K, Ghannoum MA, Nyirjesy P, Sobel JD. Schwebke JR, et al. Clin Infect Dis. 2022 Jun 10;74(11):1979-1985. doi: 10.1093/cid/ciab750. Clin Infect Dis. 2022. PMID: 34467969 Free PMC article. Clinical Trial.
Treatment for recurrent vulvovaginal candidiasis (thrush).
Cooke G, Watson C, Deckx L, Pirotta M, Smith J, van Driel ML. Cooke G, et al. Cochrane Database Syst Rev. 2022 Jan 10;1(1):CD009151. doi: 10.1002/14651858.CD009151.pub2. Cochrane Database Syst Rev. 2022. PMID: 35005777 Free PMC article.
Prevalence, risk factors and adverse pregnancy outcomes of second trimester bacterial vaginosis among pregnant women in Bukavu, Democratic Republic of the Congo.
Mulinganya G, De Vulder A, Bisimwa G, Boelens J, Claeys G, De Keyser K, De Vos D, Hendwa E, Kampara F, Kujirakwinja Y, Mongane J, Mubalama I, Vaneechoutte M, Callens S, Cools P. Mulinganya G, et al. PLoS One. 2021 Oct 25;16(10):e0257939. doi: 10.1371/journal.pone.0257939. eCollection 2021. PLoS One. 2021. PMID: 34695126 Free PMC article.
Vulvovaginal candidiasis and current perspectives: new risk factors and laboratory diagnosis by using MALDI TOF for identifying species in primary infection and recurrence.
Pereira LC, Correia AF, da Silva ZDL, de Resende CN, Brandão F, Almeida RM, de Medeiros Nóbrega YK. Pereira LC, et al. Eur J Clin Microbiol Infect Dis. 2021 Aug;40(8):1681-1693. doi: 10.1007/s10096-021-04199-1. Epub 2021 Mar 13. Eur J Clin Microbiol Infect Dis. 2021. PMID: 33713006 Free PMC article.
860 results